1. Home
  2. PRAX vs AFG Comparison

PRAX vs AFG Comparison

Compare PRAX & AFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$331.79

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo American Financial Group Inc.

AFG

American Financial Group Inc.

HOLD

Current Price

$130.74

Market Cap

11.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
AFG
Founded
2015
1872
Country
United States
United States
Employees
N/A
8700
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
11.1B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
PRAX
AFG
Price
$331.79
$130.74
Analyst Decision
Strong Buy
Hold
Analyst Count
15
4
Target Price
$572.13
$141.00
AVG Volume (30 Days)
345.8K
377.8K
Earning Date
05-01-2026
04-29-2026
Dividend Yield
N/A
2.69%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6,395.88
$4.61
P/E Ratio
N/A
$12.86
Revenue Growth
N/A
N/A
52 Week Low
$28.79
$120.52
52 Week High
$354.87
$150.02

Technical Indicators

Market Signals
Indicator
PRAX
AFG
Relative Strength Index (RSI) 57.17 55.63
Support Level $282.49 $129.99
Resistance Level $327.65 $134.17
Average True Range (ATR) 17.60 2.51
MACD 2.86 0.54
Stochastic Oscillator 81.68 66.17

Price Performance

Historical Comparison
PRAX
AFG

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About AFG American Financial Group Inc.

American Financial Group Inc is an insurance holding company. Through its subsidiaries, it is engaged in the property and casualty insurance business, focusing on specialized commercial products for businesses. The group operates through two segments: Property and Casualty Insurance, which generates maximum revenue, and Other. The Property and Casualty Insurance segment is further divided into different sub-segments, such as Property and transportation, Specialty casualty, and Specialty financial. These sub-segments offer insurance coverage for vehicles and commercial property, customized programs for small to mid-sized businesses, workers' compensation insurance, risk management insurance programs for lending and leasing institutions, trade credit insurance, and other insurance products.

Share on Social Networks: